Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.235 USD | +2.52% | +3.29% | -33.31% |
Mar. 20 | HC Wainwright Adjusts Coherus BioSciences' Price Target to $11 From $13, Keeps Buy Rating | MT |
Mar. 14 | Coherus BioSciences Shares Fall After Workforce Reduction Plan; Q4 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.31% | 247M | |
-0.38% | 103B | |
+3.47% | 96.73B | |
+1.66% | 21.31B | |
-16.11% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-23.06% | 13.68B | |
+6.69% | 13.44B | |
+23.16% | 10.98B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- HC Wainwright Adjusts Price Target on Coherus BioSciences to $30 From $36, Keeps Buy Rating